PL310125A1 - Steroids for use in treating menopausal aliments - Google Patents

Steroids for use in treating menopausal aliments

Info

Publication number
PL310125A1
PL310125A1 PL94310125A PL31012594A PL310125A1 PL 310125 A1 PL310125 A1 PL 310125A1 PL 94310125 A PL94310125 A PL 94310125A PL 31012594 A PL31012594 A PL 31012594A PL 310125 A1 PL310125 A1 PL 310125A1
Authority
PL
Poland
Prior art keywords
aliments
steroids
treating menopausal
menopausal
treating
Prior art date
Application number
PL94310125A
Other versions
PL182901B1 (en
Inventor
Hubert Jan Jozef Loozen
Lodewijk Pieter Cornelis Schot
De Werf-Pieters Jane Margr Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PL310125A1 publication Critical patent/PL310125A1/en
Publication of PL182901B1 publication Critical patent/PL182901B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007—Cyclic thioketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL94310125A 1993-02-08 1994-02-04 Steroids for use in treating menopausal aliments PL182901B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93200332 1993-02-08
PCT/EP1994/000348 WO1994018224A1 (en) 1993-02-08 1994-02-04 Steroids for treating menopausal complaints

Publications (2)

Publication Number Publication Date
PL310125A1 true PL310125A1 (en) 1995-11-27
PL182901B1 PL182901B1 (en) 2002-03-29

Family

ID=8213615

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94310125A PL182901B1 (en) 1993-02-08 1994-02-04 Steroids for use in treating menopausal aliments

Country Status (15)

Country Link
EP (1) EP0682672A1 (en)
JP (1) JPH08506116A (en)
KR (1) KR100364113B1 (en)
CN (1) CN1046735C (en)
AU (1) AU4675897A (en)
BR (1) BR9405825A (en)
CA (1) CA2155532A1 (en)
FI (1) FI114101B (en)
HU (2) HU220615B1 (en)
NO (1) NO308583B1 (en)
NZ (1) NZ261581A (en)
PL (1) PL182901B1 (en)
RU (1) RU2172740C2 (en)
WO (1) WO1994018224A1 (en)
ZA (1) ZA94715B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity
NZ506115A (en) * 1998-03-09 2003-07-25 Akzo Nobel Nv Contraceptive kit containing a compound with both estrogenic and progestagenic activity
PL353826A1 (en) * 1999-09-06 2003-12-01 Akzo Nobel N.V.Akzo Nobel N.V. Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
SK882003A3 (en) 2000-07-28 2003-07-01 Akzo Nobel Nv 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use
UA89964C2 (en) 2004-09-08 2010-03-25 Н.В. Органон 15beta-substituted steroids having selective estrogenic activity
EP3865501A1 (en) * 2016-03-03 2021-08-18 Crystal Pharma, S.A.U. New intermediates for the preparation of 11-methylene steroids

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325520A (en) * 1965-12-08 1967-06-13 Searle & Co (optionally 17-hydrocarbon-substituted) 11, 13beta-dialkylgon-4-en-3-ones and esters corresponding
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
NL175063C (en) * 1972-12-09 1984-09-17 Akzo Nv PROCESS FOR THE PREPARATION OF 11,11-ALKYLIDE STEROIDS, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND FORMED PHARMACEUTICAL PREPARATIONS.
US3927046A (en) * 1972-12-09 1975-12-16 Akzona Inc Novel 11,11-alkylidene steroids
NL7317358A (en) * 1973-12-19 1975-06-23 Akzo Nv NEW 11 (BETA) ALKYL STEROIDS FROM THE OESTRAAN SERIES.
NL7701384A (en) * 1977-02-10 1978-08-14 Akzo Nv PROCESS FOR PREPARING NEW STEROIDS FROM THE OESTRAINE SERIES.
AU532512B2 (en) * 1979-09-07 1983-10-06 Upjohn and Horton Anti-allergenic compounds for bone mineral resorption
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
NL8502571A (en) * 1985-09-20 1987-04-16 Akzo Nv Steroidal immuno-modulators - comprising 4-oestrene derivs.
DE3702383A1 (en) * 1987-01-23 1988-08-04 Schering Ag 11SS-ALKINYLESTRENE AND -ESTRADIENE, THEIR PRODUCTION AND THEIR PHARMACEUTICAL PREPARATIONS CONTAINING THEM
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
ES2062191T3 (en) * 1990-06-14 1994-12-16 Henning Berlin Gmbh PREPARED FROM PLUG-IN CAPSULES, FILLED WITH LIQUID.
AU8166191A (en) * 1990-08-10 1992-02-13 Ortho Pharmaceutical Corporation Method for treatment of bone wasting diseases

Also Published As

Publication number Publication date
RU2172740C2 (en) 2001-08-27
BR9405825A (en) 1995-12-05
AU682170B2 (en) 1997-09-25
CN1046735C (en) 1999-11-24
CA2155532A1 (en) 1994-08-18
AU4675897A (en) 1998-02-19
FI114101B (en) 2004-08-13
HU0102320D0 (en) 2001-08-28
NZ261581A (en) 1997-06-24
NO953089L (en) 1995-10-06
NO953089D0 (en) 1995-08-07
KR100364113B1 (en) 2003-04-08
FI953747A0 (en) 1995-08-07
AU6039494A (en) 1994-08-29
WO1994018224A1 (en) 1994-08-18
HU9501940D0 (en) 1995-09-28
NO308583B1 (en) 2000-10-02
HU220615B1 (en) 2002-03-28
HUT72971A (en) 1996-06-28
CN1117735A (en) 1996-02-28
JPH08506116A (en) 1996-07-02
PL182901B1 (en) 2002-03-29
EP0682672A1 (en) 1995-11-22
ZA94715B (en) 1994-10-24
FI953747A (en) 1995-09-12

Similar Documents

Publication Publication Date Title
AP9300539A0 (en) Steroidal glycosides for treating hypercholest erolemia
ZA925391B (en) Trifluoromethylbenzylphosphonates useful in treating osteoporosis
GB2277450B (en) Device for use in lithotrity
ZA95701B (en) Rivets-nails and methods for their implementation
GB9303749D0 (en) Crushing apparatus
HK1011820A1 (en) Method for implementing switching in time or space domain
IL110656A0 (en) Shut off in shower apparatus
PL310125A1 (en) Steroids for use in treating menopausal aliments
ZA913184B (en) Composition for treating osteoporosis and hormonal imbalance
GB2290011B (en) Relay apparatus
GB9320897D0 (en) Compounds useful in anti-allergy treatment
GB9420539D0 (en) Process and composition
OA09957A (en) Panel structure and panel for use in forming such structure
GB9224477D0 (en) Improvements in bodyforms
GB2301067B (en) Cargo retention apparatus
GB9209352D0 (en) Improvements in cooking devices
GB2294105B (en) Improvements in decontamination
GB9504832D0 (en) Improvements in lockig means
HU9500100D0 (en) Built in apparatus
GB9219126D0 (en) Improvements in orreries
GB2268712B (en) Improvements in life-jackets
GB9112745D0 (en) Improvements in panel fitting
GB9200115D0 (en) Improvements in impact-delivering apparatus
GB9423982D0 (en) Improvements in washing lines
GB9113464D0 (en) Improvements in card-laminating processes

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20060204